ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ONVO Organovo Holdings Inc

1.04
0.01 (0.97%)
22 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Organovo Holdings Inc NASDAQ:ONVO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.01 0.97% 1.04 1.02 1.04 1.06 1.01 1.05 50,993 22:25:28

Current Report Filing (8-k)

26/07/2016 1:06pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 26, 2016

 

 

ORGANOVO HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

Commission File Number: 001-35996

 

Delaware     27-1488943

(State or other jurisdiction

of incorporation)

   

(I.R.S. Employer

Identification No.)

6275 Nancy Ridge Drive, Suite 110

San Diego, CA 92121

(Address of principal executive offices, including zip code)

(858) 224-1000

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On July 26, 2016, Organovo Holdings, Inc. (the “Company”) provided written notice to the NYSE MKT (“NYSE MKT”) of its intention to voluntarily delist its common stock, $0.001 par value per share (“Common Stock”), on the NYSE MKT and to list its Common Stock on the Nasdaq Global Market of The Nasdaq Stock Market LLC (“Nasdaq”). The Company expects the listing and trading of its Common Stock on the NYSE MKT will cease at market close on August 5, 2016, and that trading of its Common Stock will commence on Nasdaq on August 8, 2016. The Common Stock has been approved for listing on Nasdaq, with the Common Stock continuing to trade under the symbol “ONVO.”

A copy of the press release issued by the Company announcing the transfer to Nasdaq is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

 

Exhibit

No.

  

Description

99.1    Press release, dated July 26, 2016.

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ORGANOVO HOLDINGS, INC.
Date: July 26, 2016     By:  

/s/ Keith Murphy

    Name:   Keith Murphy
    Title:   Chief Executive Officer and President

 

3


Exhibit Index

 

Exhibit

No.

  

Description

99.1    Press release, dated July 26, 2016.

1 Year Organovo Chart

1 Year Organovo Chart

1 Month Organovo Chart

1 Month Organovo Chart